| 产品描述: | RUNX 抑制剂;RUNX Inhibitors;;InformationCADD522 CADD522 is a potent inhibitor of RUNX2(runt-related transcription factor-2)-DNA binding with IC50 of 10 nM. CADD522 exhibits anticancer activity.TargetsRUNX2-DNA (Cell-free assay) 10 nM |
| 体内研究: |
CADD522 (1、5 和 20 mg/kg;腹腔注射;每周两次,持续 45 天) 延缓肿瘤的发生并抑制小鼠肿瘤的生长。 CADD522 (10 mg/kg;腹腔注射;每周两次,持续 11 天) 抑制肿瘤转移并抑制小鼠 Ki-67 的表达。 |
| 参考文献: |
1. Kim MS, et al. Characterization of CADD522, a small molecule that inhibits RUNX2-DNA binding and exhibits antitumor activity. Oncotarget. 2017 Aug 10;8(41):70916-70940. 2. Kim MS, et al. Targeting breast cancer metabolism with a novel inhibitor of mitochondrial ATP synthesis. Oncotarget. 2020 Oct 27;11(43):3863-3885. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
3.066 ml |
15.329 ml |
30.659 ml |
| 5 mM |
0.613 ml |
3.066 ml |
6.132 ml |
| 10 mM |
0.307 ml |
1.533 ml |
3.066 ml |
| 50 mM |
0.061 ml |
0.307 ml |
0.613 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |